Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

84.99
Delayed Data
As of Aug 14
 -0.90 / -1.05%
Today’s Change
31.99
Today|||52-Week Range
91.77
+98.99%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Kakkis Emil D
President & Chief Executive Officer
Sale7/13/202040,000$85.35$3.4M+3.86%
Siegall Clay B
Director
Sale8/07/202023,404$85.55$2.0M+0.32%
Aliski William E
Director
Sale5/18/202020,000$74.02$1.5M+17.25%
Sharp Shalini
Chief Financial Officer & Executive Vice President
Sale5/18/202019,593$73.34$1.4M+17.25%
Sharp Shalini
Chief Financial Officer & Executive Vice President
Buy5/18/202019,593$70.57$1.4M+17.25%
Siegall Clay B
Director
Sale8/10/20209,750$85.01$828.8K-0.05%
Sharp Shalini
Chief Financial Officer & Executive Vice President
Sale6/03/202010,234$74.23$759.7K+17.39%
Aliski William E
Director
Sale5/18/20207,500$74.65$559.9K+17.25%
Fust Matthew K
Director
Sale7/06/20206,181$90.00$556.3K-1.89%
Sharp Shalini
Chief Financial Officer & Executive Vice President
Buy6/03/202010,234$48.43$495.6K+17.39%
Page of 12